MedTrace Logo

Influence of Dexmedetomidine on a Closed-Loop Anesthesia System

NCT00921284 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2016-09-23

No results posted yet for this study

Summary

The main objective if to evaluate the sparing effect of dexmedetomidine on the doses of propofol and remifentanil.

Conditions

  • Anesthesia

Interventions

DRUG

NaCl 9/00

Same volume as in the dexmedetomidine group

DRUG

dexmedetomidine

1 mcg/kg administered in 10 minutes followed by a continuous infusion of 0,5 mcg/kg/hr

Sponsors & Collaborators

  • Hopital Foch

    lead OTHER

Principal Investigators

  • Marc Fischler, MD · Hopital Foch

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2011-07-31
Completion
2011-07-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00921284 on ClinicalTrials.gov